Us Mefenamic Acid Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Mefenamic Acid Market was valued at USD 0.45 Billion in 2022 and is projected to reach USD 0.62 Billion by 2030, growing at a CAGR of 5.1% from 2024 to 2030.
The US Mefenamic Acid Market is poised for steady growth due to its wide usage as a nonsteroidal anti-inflammatory drug (NSAID). This drug is primarily used to treat mild to moderate pain, often related to menstrual cramps, as well as its application in managing arthritis and other inflammatory conditions. Over the past few years, the demand for Mefenamic Acid has risen due to an increasing focus on pain management therapies, coupled with the growing awareness of the importance of non-opioid alternatives in treating pain.
As a significant player in the pharmaceutical landscape, Mefenamic Acid is mainly marketed through prescription forms, which have gained favor over over-the-counter pain relievers due to their efficacy in treating more complex pain conditions. The market has also been influenced by factors such as an aging population, rising healthcare expenditures, and the prevalence of conditions like arthritis, all of which require effective anti-inflammatory solutions.
Recent trends suggest that Mefenamic Acid’s market expansion is also being driven by the increasing prevalence of women’s health issues, particularly menstrual pain, which accounts for a large portion of its usage. Furthermore, as consumers seek alternatives to opioid-based pain management, Mefenamic Acid is emerging as a preferred option due to its safety profile and efficacy in managing pain without the addictive risks associated with opioids.
The US Mefenamic Acid Market is characterized by a competitive landscape, with key pharmaceutical manufacturers producing various formulations of the drug. These include tablets, capsules, and liquid formulations that cater to different patient preferences. Additionally, the market benefits from robust distribution networks that ensure availability in pharmacies and hospitals across the country.
According to the market dynamics, the demand for Mefenamic Acid is expected to grow steadily in the coming years. Innovations in formulation and the increasing awareness of its benefits in pain management are expected to drive this growth, making it a key player in the broader NSAID market. Furthermore, as the healthcare industry continues to evolve, Mefenamic Acid remains a critical component in non-opioid pain relief, securing its place in the US pharmaceutical market alongside other major drugs.
The US Mefenamic Acid Market is also expected to benefit from cross-market synergies. For example, the development of new technologies in related sectors, such as the 100 Gigabit Fiber Optic Transceiver Market, could offer new avenues for distribution and marketing within the pharmaceutical sector. This interconnectivity highlights the ever-evolving nature of the healthcare and pharmaceutical industries, and how technological advancements outside traditional healthcare sectors can influence market dynamics.
Get an In-Depth Research Analysis of the Global Mefenamic Acid Market Size And Forecast [2025-2032]
Â
Shionogi Pharma
Solitaire Pharmacia
Shinto Organics
Captab
EMS Pharma
Adelco
Agron Remedies
IASIS Pharmaceuticals Hellas
ABL Lifecare
Farmo Quimica
Apotex
Sanofi Aventis
Yung Sine
Streuli Pharma
Mankind
Pfizer
Daiichi Sankyo
Chemidex Pharma
AA Pharma
Nisshin Pharmaceutical
Koa Isei
Teva
Wockhardt
Esteve
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Mefenamic Acid Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Mefenamic Acid Market
Tablet
Capsule
Suspension
Injectable
Pain Relief
Menstrual Disorders
Anti-inflammatory Treatments
Postoperative Pain Management
Pharmacies
Online Pharmacies
Hospital Pharmacies
Retail Stores
Hospitals
Clinics
Homecare Settings
Nursing Facilities
250 mg
500 mg
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Mefenamic Acid Market Research Analysis
1. Introduction of the Global Mefenamic Acid Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Mefenamic Acid Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Mefenamic Acid Market, By Type
6. Global Mefenamic Acid Market, By Application
7. Global Mefenamic Acid Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Mefenamic Acid Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/